Celebrating One Year of the Investor Catalyst Hub!

Celebrating one year of the ARPA-H Investor Catalyst Hub, part of the ARPANET-H health innovation network; IC Hub logo; words with confetti on a teal and blue background

By Chelsea Schiller, director, ARPA-H Investor Catalyst Hub

This article originally appeared on the ARPA-H Investor Catalyst Hub blog.

Just over a year ago, the Advanced Research Projects Agency for Health (ARPA-H) launched the Investor Catalyst (IC) Hub as part of ARPANET-H—a nationwide health innovation network. The IC Hub is on a mission to support ARPA-H program development.

We’ve been busy! Although I’m excited to jump into our second year, I wanted to reflect on our first year’s highlights and give credit to those who have contributed to our success.

Reflecting on Year One

Our first year was all about growth.

We built a diverse network from coast to coast with many of the brightest minds and leaders in health innovation. From 10 inaugural members to nearly 600 members today, our ever growing network spans the public, private, and nonprofit sectors. It represents nearly two dozen sectors and service areas. Of our members, almost 250 are designated small businesses, more than 150 have been operating for fewer than five years, more than 100 are women-owned, and more than 75 are minority-owned. This is important to us as we work to serve as the front door to the agency for our broader network, but most importantly for underrepresented organizations, companies, and institutions that haven’t previously received federal funding.

Like the IC Hub, ARPA-H is still a young agency. In only two and a half years, ARPA-H has launched 19 programs and has allocated $1.5 billion for transformative health solutions. Our growth is intertwined, and as ARPA-H continues to build its portfolio of projects and investments, the IC Hub will follow.

As I mentioned in my interview with the Boston Business Journal in the spring, the IC Hub is best positioned to support ARPA-H program development by leveraging its network—and our hub’s network is now bigger, more diverse, and more capable of providing the expertise, solutions, and support than ever before.

We are excited to celebrate the 30 IC Hub members who have already received a total of more than $936 million in funding from ARPA-H. Last month, Cellino was awarded $25 million from ARPA-H to support the NExt-generation Biomanufacturing ULtra-scalable Approach (NEBULA) project.

Milestones and Achievements

The IC Hub has, so far, directly supported 21 ARPA-H programs and Mission Offices. Our team led successful communications campaigns to build visibility for ARPA-H programs, connected programs to network experts and hosted ARPA-H programs in our network webinar series to create linkages between ARPA-H programs and potential proposers. Most notably, within our first six months, we launched our first sprint and first network survey in collaboration with ARPA-H.

ARPA-H Sprint for Women’s Health

I was honored to be in the room when ARPA-H officially launched the Sprint for Women’s Health with Dr. Jill Biden in February. This sprint is a funding initiative conducted in collaboration with the IC Hub that committed $100 million toward transformative research and development in women’s health. ARPA-H received an unprecedented number of submissions from 45 states; Washington, D.C.; and 34 countries—making it clear that there is an overwhelming demand for solutions to women’s health challenges. We are excited to announce the Sprint for Women’s Health performers this month—the finish line to an incredible funding round and the starting line to accelerating breakthroughs in women’s health.
ARPA-H Medical Imaging Data Marketplace Network Survey and Report

In support of a joint effort by ARPA-H and the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA), the IC Hub issued our first network survey in March, seeking expert feedback to streamline access to affordable, high-quality, regulatory-ready medical imaging data at scale. Our network answered the call, and in August, we published the findings from the survey, which shared valuable insights from our network on data standardization, interoperability, security, affordability, and access, which can support ARPA-H in shaping programs and initiatives in this area.

Investor Catalyst hub timeline graphic; September 26, 2023: VentureWell selected as consortium management firm for Investor Catalyst (IC) Hub; October 26, 2023: IC Hub hosts launch event in Cambridge with ARPA-H and inaugural spokes; December 2023: 100 spokes; February 21, 2024: IC Hub supports ARPA-H Sprint for Women’s Health launch; March 2024: IC Hub issues first network survey for medical imaging data marketplace; April 2024: 200 spokes; May 23, 2024: Boston Business Journal features IC Hub Director Chelsea Schiller; June 2024: 300 spokes; August 20, 2024: IC Hub publishes medical imaging data marketplace network survey report; August 22, 2024: IC Hub releases new community feature in member portal; August 2024: 500 spokes; September 26, 2024 IC Hub Celebrates its first year; October 17, 2024 IC Hub hosts network showcase

Looking Ahead

Our second year will be all about impact.

When the IC Hub first launched, we outlined network growth goals to achieve by the end of our first year. We didn’t just meet those goals—we surpassed them. We plan to turn this growth into impact by activating our network to achieve ARPA-H program goals. As a result of continued member engagement, I’m confident that the IC Hub will serve ARPA-H’s mission of accelerating better health outcomes for everyone.

If you’re not yet a part of the IC Hub network, I invite you to apply to join the network.

It has been an incredible inaugural year for the IC Hub. Thank you to ARPA-H for being a visionary partner, to the IC Hub team for your tremendous commitment to this important work, and most importantly, to our network who are at the forefront of innovative health solutions.

Sign Up for the VentureWell Newsletter

×

    I'd best describe myself as a:

    By continuing to use the site, you agree to the use of cookies. Read More